The FDA CR

This topic has expert replies
Legendary Member
Posts: 1169
Joined: Sun Jul 06, 2008 2:34 am
Thanked: 25 times
Followed by:1 members

The FDA CR

by aj5105 » Mon May 11, 2009 2:07 am
The United States Food and Drug Administration (FDA) regulates the introduction of new therapeutic agents into the marketplace. Consequently, it plays a critical role in improving health care in the United States. While it is those in the academic and government research communities who engage in the long process of initial discovery and clinical testing of new therapeutic agents, it is the FDA’s role and responsibility to facilitate the transfer of new discoveries from the laboratory to the marketplace. Only after the transfer can important new therapies help patients.
Which one of the following statements can be inferred from the passage?

(A) The FDA is responsible for ensuring that any therapeutic agent that is marketed is then regulated.

(B) Before new therapeutic agents reach the marketplace they do not help patients.

(C) The research community is responsible for the excessively long testing period for new drugs, not the FDA.

(D) The FDA should work more closely with researchers to ensure that the quality of therapeutic agents is maintained.

(E) If a new medical discovery has been transferred from the laboratory to the marketplace, it will help patients.

Senior | Next Rank: 100 Posts
Posts: 59
Joined: Tue May 05, 2009 1:58 am
Thanked: 1 times

Re: The FDA CR

by Pranay » Mon May 11, 2009 2:59 am
aj5105 wrote:The United States Food and Drug Administration (FDA) regulates the introduction of new therapeutic agents into the marketplace. Consequently, it plays a critical role in improving health care in the United States. While it is those in the academic and government research communities who engage in the long process of initial discovery and clinical testing of new therapeutic agents, it is the FDA’s role and responsibility to facilitate the transfer of new discoveries from the laboratory to the marketplace. Only after the transfer can important new therapies help patients.
Which one of the following statements can be inferred from the passage?

(A) The FDA is responsible for ensuring that any therapeutic agent that is marketed is then regulated.

(B) Before new therapeutic agents reach the marketplace they do not help patients.

(C) The research community is responsible for the excessively long testing period for new drugs, not the FDA.

(D) The FDA should work more closely with researchers to ensure that the quality of therapeutic agents is maintained.

(E) If a new medical discovery has been transferred from the laboratory to the marketplace, it will help patients.
I go with D.

Please post the correct answer and will post my way of deducing the answer, if correct.

Legendary Member
Posts: 876
Joined: Thu Apr 10, 2008 8:14 am
Thanked: 13 times

by ketkoag » Mon May 11, 2009 3:51 am
IMO B

Junior | Next Rank: 30 Posts
Posts: 14
Joined: Thu Apr 30, 2009 7:40 am
Location: Hyderabad

by preetosh » Mon May 11, 2009 8:26 am
I was confused a bit between B and E , but will go with B

OA please?

Master | Next Rank: 500 Posts
Posts: 221
Joined: Wed Jan 21, 2009 10:33 am
Thanked: 12 times
Followed by:1 members

by krisraam » Mon May 11, 2009 8:47 am
IMO E.

Thanks
Raama

Master | Next Rank: 500 Posts
Posts: 377
Joined: Wed Sep 03, 2008 9:30 am
Thanked: 15 times
Followed by:2 members

by schumi_gmat » Mon May 11, 2009 9:13 am
IMO B

(A) The FDA is responsible for ensuring that any therapeutic agent that is marketed is then regulated.
Introduction of therapies are regulated........first sentence


(B) Before new therapeutic agents reach the marketplace they do not help patients.
correct........Last stmt


(C) The research community is responsible for the excessively long testing period for new drugs, not the FDA.

Extreme word, excessively

(D) The FDA should work more closely with researchers to ensure that the quality of therapeutic agents is maintained.
IRrelevant

(E) If a new medical discovery has been transferred from the laboratory to the marketplace, it will help patients. There is a possibility not certainty in the argument

Legendary Member
Posts: 1161
Joined: Mon May 12, 2008 2:52 am
Location: Sydney
Thanked: 23 times
Followed by:1 members

by mehravikas » Mon May 11, 2009 1:00 pm
IMO - B

Argument - Only after the transfer can important new therapies help patients.

Therefore, B can be inferred from the argument.

User avatar
Legendary Member
Posts: 575
Joined: Tue Nov 04, 2008 2:58 am
Location: India
Thanked: 18 times
Followed by:4 members
GMAT Score:710

by rahulg83 » Tue May 12, 2009 9:42 pm
IMO B...

E says
If a new medical discovery has been transferred from the laboratory to the marketplace, it will help patients.
I guess "medical discoveries" are different from "therapeutic agents". Medical discoveries is a too general term to attribute it to helping of patients.
Please post the OA

Master | Next Rank: 500 Posts
Posts: 154
Joined: Mon Apr 13, 2009 10:57 pm
Thanked: 3 times

Re: The FDA CR

by thetrystero » Wed May 13, 2009 1:05 am
aj5105 wrote:The United States Food and Drug Administration (FDA) regulates the introduction of new therapeutic agents into the marketplace. Consequently, it plays a critical role in improving health care in the United States. While it is those in the academic and government research communities who engage in the long process of initial discovery and clinical testing of new therapeutic agents, it is the FDA’s role and responsibility to facilitate the transfer of new discoveries from the laboratory to the marketplace. Only after the transfer can important new therapies help patients.
Which one of the following statements can be inferred from the passage?

(A) The FDA is responsible for ensuring that any therapeutic agent that is marketed is then regulated.

(B) Before new therapeutic agents reach the marketplace they do not help patients.

(C) The research community is responsible for the excessively long testing period for new drugs, not the FDA.

(D) The FDA should work more closely with researchers to ensure that the quality of therapeutic agents is maintained.

(E) If a new medical discovery has been transferred from the laboratory to the marketplace, it will help patients.

My answer: C
1. Researchers discover drugs and perform testing
2. FDA transfers drug from lab to market
3. After transfer, drug can help patients.

A,B,D are nowhere stated in the problem.
E: problem says that drugs "can" help the patient, but it is not a 100% guarantee that they will.
C: same as what is said in the problem statement.

Master | Next Rank: 500 Posts
Posts: 154
Joined: Mon Apr 13, 2009 10:57 pm
Thanked: 3 times

by thetrystero » Wed May 13, 2009 1:12 am
I'm swayed. looks like B it is.

Master | Next Rank: 500 Posts
Posts: 145
Joined: Mon Feb 16, 2009 8:41 am
Thanked: 2 times
Followed by:2 members

by anshulseth » Wed May 13, 2009 9:05 pm
The whole Q stem talks abt FDA. Where is it lost in B? That rules it out.

IMO D. As argument says that though researches do the testing for the agents, but its FDA who finally passes it to marketplace. If they work closely with researchers, the quality of the agents can be maintained.
Asset

Master | Next Rank: 500 Posts
Posts: 154
Joined: Mon Apr 13, 2009 10:57 pm
Thanked: 3 times

by thetrystero » Wed May 13, 2009 9:46 pm
@aj5105 OA please.

Master | Next Rank: 500 Posts
Posts: 371
Joined: Fri Mar 06, 2009 2:48 am
Thanked: 27 times
GMAT Score:740

by 2010gmat » Thu May 14, 2009 1:34 am
B :D

Only after the transfer can important new therapies help patients.

THATS WAT b SAYS

Senior | Next Rank: 100 Posts
Posts: 87
Joined: Sun Apr 19, 2009 11:07 pm

Re: The FDA CR

by success1111 » Thu May 14, 2009 9:22 am
aj5105 wrote:The United States Food and Drug Administration (FDA) regulates the introduction of new therapeutic agents into the marketplace. Consequently, it plays a critical role in improving health care in the United States. While it is those in the academic and government research communities who engage in the long process of initial discovery and clinical testing of new therapeutic agents, it is the FDA’s role and responsibility to facilitate the transfer of new discoveries from the laboratory to the marketplace. Only after the transfer can important new therapies help patients.
Which one of the following statements can be inferred from the passage?

(A) The FDA is responsible for ensuring that any therapeutic agent that is marketed is then regulated.

(B) Before new therapeutic agents reach the marketplace they do not help patients.

(C) The research community is responsible for the excessively long testing period for new drugs, not the FDA.

(D) The FDA should work more closely with researchers to ensure that the quality of therapeutic agents is maintained.

(E) If a new medical discovery has been transferred from the laboratory to the marketplace, it will help patients.
Apply contrapositive.
"Only after the transfer can important new therapies help patients."

The contrapositive of this sentence is "before transfer,new therapies do not help",which is essentially what B says. Choose B with confidence.
Trust but verify.

Newbie | Next Rank: 10 Posts
Posts: 1
Joined: Wed May 13, 2009 8:19 am

by wondering » Thu May 14, 2009 9:35 am
IMO B